US2008089952A1PendingUtilityA1

Compositions and methods for coating medical implants

Assignee: ANGIOTECH INT AGPriority: May 24, 2002Filed: Jul 31, 2007Published: Apr 17, 2008

Est. expiryMay 24, 2022(expired)· nominal 20-yr term from priority

Inventors:William L. Hunter David Gravett Philip M. Toleikis Richard Liggins Troy Loss

A61L 29/085A61L 2300/416A61L 2300/404A61P 43/00A61L 29/16A61L 27/34A61L 27/54A61P 31/00

PatentIndex Score

Cited by

References

Claims

Abstract

Medical implants are provided which release an anthracycline, fluoropyrimidine, folic acid antagonist, podophylotoxin, camptothecin, hydroxyurea, and/or platinum complex, thereby inhibiting or reducing the incidence of infection associated with the implant.

Claims

exact text as granted — not AI-modified

1 .- 18 . (canceled)  
     
     
         19 . A method for reducing or inhibiting infection associated with a medical implant, comprising the step of introducing into a patient a medical implant which has been covered or coated with an anthracycline, fluoropyrimidine, folic acid antagonist, podophylotoxin, camptothecin, hydroxyurea, or platinum complex.  
     
     
         20 . The method according to  claim 19  wherein said fluoropyrimidine is 5-fluorouracil.  
     
     
         21 .- 23 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.